W 272 (Lamotrigine Extended-Release 200 mg)
Pill with imprint W 272 is Pink, Round and has been identified as Lamotrigine Extended-Release 200 mg. It is supplied by Wockhardt USA LLC.
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for W 272
Lamotrigine Extended-Release
- Imprint
- W 272
- Strength
- 200 mg
- Color
- Pink
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Wockhardt USA LLC
- National Drug Code (NDC)
- 64679-0272 (Discontinued)
- Inactive Ingredients
-
diethyl phthalate,
ferric oxide red,
hypromelloses,
lactose monohydrate,
magnesium stearate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
polyethylene glycol,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "W 272"
More about lamotrigine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,549)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: triazine anticonvulsants
Patient resources
- Drug Information
- Lamotrigine Extended-Release Tablets
- Lamotrigine Tablets
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Orally Disintegrating Tablets
Other brands
Lamictal, Lamictal XR, Lamictal ODT, Subvenite, Lamictal CD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.